Overview
Fibrosarcomatous dermatofibrosarcoma protuberans (DFSP) represents an aggressive variant of dermatofibrosarcoma protuberans (DFSP), characterized by a higher risk of local recurrence and potential for metastasis compared to conventional DFSP. This rare subtype is distinguished histologically by the presence of heterologous elements resembling fibrosarcoma within the typical DFSP architecture. Clinically, fibrosarcomatous DFSP often presents with larger, more aggressive tumors that may require meticulous surgical planning and multidisciplinary management to achieve optimal outcomes. Understanding the epidemiology, clinical presentation, diagnostic criteria, and management strategies is crucial for effective patient care and surveillance.
Epidemiology
Fibrosarcomatous DFSP is a rare variant of DFSP, with limited large-scale epidemiological data available. Recurrences following primary tumor resection are a significant concern, typically occurring at a median interval of 26 months (±23.3 months) [PMID:32952057]. This prolonged latency period underscores the need for long-term follow-up in these patients. The rarity and variability in reporting make it challenging to establish definitive incidence rates, but clinical experience suggests that these aggressive variants may be underrepresented in broader DFSP studies. Given the aggressive nature, early detection and precise surgical management are critical to mitigate recurrence risks.
Clinical Presentation
Patients with fibrosarcomatous DFSP often present with larger, more symptomatic tumors compared to conventional DFSP. In a cohort of 33 patients, tumors predominantly manifested on the trunk, reflecting a common anatomical predilection [PMID:27643548]. A notable case described a 36-year-old male with a massive recurrent tumor arising from the left upper anterior chest wall, highlighting the potential for significant local invasion and recurrence [PMID:16612932]. These tumors can grow insidiously, often presenting as firm, subcutaneous masses that may be tender or asymptomatic initially. The variability in size and location necessitates thorough physical examination and imaging to guide appropriate management strategies.
Diagnosis
Diagnosis of fibrosarcomatous DFSP relies heavily on histopathologic evaluation and immunohistochemical staining. Histologic examination typically reveals the characteristic features of DFSP, with additional fibrosarcomatous elements such as increased cellularity, pleomorphism, and atypical mitotic figures [PMID:16612932]. Immunohistochemistry often confirms the diagnosis by demonstrating the presence of CD34 and factor XIIIa positivity, while excluding other spindle cell neoplasms. In a study involving patients with previously treated disease and histologically positive margins, successful outcomes were achieved through meticulous surgical techniques, emphasizing the importance of accurate initial diagnosis and margin assessment [PMID:27643548]. Advanced imaging modalities, such as MRI, can provide additional insights into tumor extent and guide surgical planning, although definitive diagnosis remains histopathologic.
Management
The management of fibrosarcomatous DFSP is primarily surgical, with the goal of achieving clear margins to minimize recurrence risk. Traditional wide excisions with generous margins are often necessary, though the impact of specific margin widths on recurrence rates remains nuanced. A study indicated that lateral and depth margins did not significantly influence local recurrence rates, suggesting that thorough resection rather than specific margin measurements may be more critical [PMID:32952057]. Paraffin-embedded micrographic surgery (PEMS) has shown promising results in managing these aggressive variants. In a retrospective analysis of 33 patients treated with PEMS between 2002 and 2015, all patients remained recurrence-free over a mean follow-up of 6.5 years, highlighting the efficacy of this meticulous surgical technique [PMID:27643548].
The surgical approach often involves staged excisions, with 60.6% of tumors completely excised in the first stage, while 33.3% required additional stages, sometimes up to six stages, to achieve clear margins [PMID:27643548]. In complex cases, reconstructive techniques such as the use of a pedicled latissimus dorsi musculocutaneous flap combined with free split skin grafts can be employed to restore function and cosmesis, as exemplified in a case report involving extensive chest wall reconstruction [PMID:16612932]. Postoperative care should focus on monitoring for complications, particularly subcutaneous tissue edema, which affected nearly all patients (88%) post-resection [PMID:32952057].
Complications
Postoperative complications following the resection of fibrosarcomatous DFSP can significantly impact patient recovery and quality of life. Subcutaneous tissue edema is a common complication, affecting 88% of patients post-resection, necessitating careful monitoring and supportive care to manage symptoms and prevent secondary issues such as infection or impaired wound healing [PMID:32952057]. Other potential complications include wound dehiscence, infection, and functional impairment related to extensive resections, particularly in areas like the chest wall. Multidisciplinary input from plastic surgeons and physical therapists can be invaluable in addressing these complications and optimizing patient outcomes.
Prognosis & Follow-up
The prognosis for fibrosarcomatous DFSP is generally guarded due to its aggressive nature, but meticulous surgical management can significantly improve outcomes. Recurrent tumors often exhibit characteristic imaging features, such as nodular and homogeneous configurations with well-defined borders and marked contrast enhancement on MRI, alongside hyperintense signals on proton density (PD)-weighted and turbo inversion recovery magnitude (TIRM) sequences [PMID:32952057]. Regular follow-up imaging, particularly MRI, plays a crucial role in early detection of recurrences, ensuring timely intervention. In the study by [PMID:27643548], no recurrences were observed in the 33 patients monitored over a mean follow-up period of 6.5 years, underscoring the effectiveness of comprehensive surgical approaches and vigilant surveillance. Clinicians should maintain a high index of suspicion for recurrence, even in patients with successful initial treatments, given the potential for late relapse.
Key Recommendations
References
1 Sedaghat S, Schmitz F, Sedaghat M, Nicolas V. Appearance of recurrent dermatofibrosarcoma protuberans in postoperative MRI follow-up. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2020. link 2 Martín-Fuentes A, De Eusebio-Murillo E, Herreros CS, Ballano-Ruiz A, Blázquez EJ, Cuevas-Santos J. Paraffin-embedded micrographic surgery for the treatment of dermatofibrosarcoma protuberans: Analysis of 33 patients. Indian journal of dermatology, venereology and leprology 2018. link 3 Kara M, Saray A, Dikmen E, Atasoy R. An uncommon soft tissue tumour of the chest wall: dermatofibrosarcoma protuberans. Acta chirurgica Belgica 2006. link